drugset
drugset / Trial / NCT00868894

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

NCT00868894 ↗

Phase 1/2 Completed 49 enrolled Santen Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate safety, efficacy, and the dose-response relationship of DE-104 in lowering intraocular pressure in Japanese and Non-Japanese subjects with primary open-angle glaucoma or ocular hypertension.

Timeline

Start
2009-03
Primary completion
2010-05
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DE-104 Unknown — Topical
Comparator Latanoprost Small molecule 0.005 % Topical

Indications

ocular hypertension open-angle glaucoma